Bioventix (BVXP) — Cash Flow-to-Debt Ratio
Bioventix (BVXP) has a Cash Flow-to-Debt Ratio of 2.23x as of December 2025, meaning its operating cash flow of GBX4.44 Million could theoretically repay 2% of its total liabilities (GBX1.99 Million) in one year. See how much free cash does Bioventix generate to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Bioventix Cash Flow-to-Debt Ratio (2011–2025)
Historical debt coverage capacity for Bioventix across 15 annual periods. Also explore how fast is Bioventix growing its equity to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Bioventix (2011–2025)
Year-by-year debt coverage analysis for Bioventix. For market capitalisation and broader financial context, see Bioventix (BVXP) market capitalisation.
| Year | CF-to-Debt Ratio | Operating CF (GBX) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 5.36x | GBX7.03 Million | GBX1.31 Million | ▲ +11.0% |
| 2024 | 4.83x | GBX8.34 Million | GBX1.73 Million | ▼ -25.6% |
| 2023 | 6.49x | GBX7.90 Million | GBX1.22 Million | ▲ +11.3% |
| 2022 | 5.83x | GBX7.56 Million | GBX1.30 Million | ▼ -0.5% |
| 2021 | 5.86x | GBX6.37 Million | GBX1.09 Million | ▼ -40.9% |
| 2020 | 9.92x | GBX7.72 Million | GBX778.87K | ▲ +32.9% |
| 2019 | 7.46x | GBX5.88 Million | GBX787.43K | ▲ +9.0% |
| 2018 | 6.85x | GBX5.92 Million | GBX864.66K | ▼ -59.1% |
| 2017 | 16.76x | GBX3.96 Million | GBX236.06K | ▲ +200.1% |
| 2016 | 5.59x | GBX3.17 Million | GBX567.86K | ▼ -17.2% |
| 2015 | 6.75x | GBX2.15 Million | GBX317.84K | ▲ +103.0% |
| 2014 | 3.33x | GBX1.77 Million | GBX530.91K | ▼ -23.8% |
| 2013 | 4.36x | GBX1.34 Million | GBX307.34K | ▼ -24.8% |
| 2012 | 5.80x | GBX1.24 Million | GBX213.54K | ▲ +44.4% |
| 2011 | 4.02x | GBX766.14K | GBX190.62K | — |